Evidence map›Paper›PMID 26695114›Full record

ArticleAmerican journal of respiratory and critical care medicine2016

Multicenter Implementation of a Treatment Bundle for Patients with Sepsis and Intermediate Lactate Values.

Vincent X Liu, John W Morehouse, Gregory P Marelich, Jay Soule, Thomas Russell, Melinda Skeath, Carmen Adams, Gabriel J Escobar, Alan Whippy

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in American journal of respiratory and critical care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04143035 (Hemodynamic Resuscitation and Monitoring in Early Sepsis), which is not on this map. Cited by 62 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 4 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04143035 unknown statusnot on this mapstarted 2019, after this paper: background citation

Hemodynamic Resuscitation and Monitoring in Early Sepsis

TypeobservationalSponsorTata Memorial CentreRan2019 to 2023Enrolled500ConditionsSeptic ShockArmsNo Intervention
3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 4 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. What is new and different in the 2021 Surviving Sepsis Campaign guidelines.Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2023
    Review
  17. Review
  18. Article
  19. Evolving Management Practices for Early Sepsis-induced Hypoperfusion: A Narrative Review.American journal of respiratory and critical care medicine · 2023
    Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Vincent X Liu1 Kaiser Permanente Division of Research, Oakland, California.
John W Morehouse2 The Permanente Medical Group, Oakland, California; and.
Gregory P Marelich2 The Permanente Medical Group, Oakland, California; and.
Jay Soule2 The Permanente Medical Group, Oakland, California; and.
Thomas Russell2 The Permanente Medical Group, Oakland, California; and.
Melinda Skeath3 Kaiser Foundation Hospitals and Health Plan, Oakland, California.
Carmen Adams3 Kaiser Foundation Hospitals and Health Plan, Oakland, California.
Gabriel J Escobar1 Kaiser Permanente Division of Research, Oakland, California.
Alan Whippy2 The Permanente Medical Group, Oakland, California; and.
Colorado Permanente Medical Group · USKaiser Foundation Hospital · USKaiser Permanente · US

Funding

Data-driven Precision medicine in sepsisK23GM112018 · NIGMS · KAISER FOUNDATION RESEARCH INSTITUTE · PI LIU, VINCENT · 2014 to 2017
$768k
NIGMS NIH HHS K23 GM112018
6 · The paper itself

Abstract

rationaleTreatments for patients with sepsis with intermediate lactate values (≥2 and <4 mmol/L) are poorly defined.

objectivesTo evaluate multicenter implementation of a treatment bundle (including timed intervals for antibiotics, repeat lactate testing, and intravenous fluids) for hemodynamically stable patients with sepsis and intermediate lactate values in the emergency department.

methodsWe evaluated patients in annual intervals before and after bundle implementation in March 2013. We evaluated bundle compliance and compared outcome measures across groups with multivariable logistic regression. Because of their perceived risk for iatrogenic fluid overload, we also evaluated patients with a history of heart failure and/or chronic kidney disease. MEASUREMENTS AND MAIN

resultsWe identified 18,122 patients with sepsis and intermediate lactate values, including 36.1% treated after implementation. Full bundle compliance increased from 32.2% in 2011 to 44.9% after bundle implementation (P < 0.01). Hospital mortality was 8.8% in 2011, 9.3% in 2012, and 7.9% in 2013 (P = 0.02). Treatment after bundle implementation was associated with an adjusted hospital mortality odds ratio of 0.81 (95% confidence interval, 0.66-0.99; P = 0.04). Decreased hospital mortality was observed primarily in patients with a heart failure and/or kidney disease history (P < 0.01) compared with patients without this history (P > 0.40). This corresponded to notable changes in the volume of fluid resuscitation in patients with heart failure and/or kidney disease after implementation.

conclusionsMulticenter implementation of a treatment bundle for patients with sepsis and intermediate lactate values improved bundle compliance and was associated with decreased hospital mortality. These decreases were mediated by improved mortality and increased fluid administration among patients with a history of heart failure and/or chronic kidney disease.

Indexed as

AgedAnti-Bacterial AgentsDrug Administration ScheduleEmergency Medical ServicesEmergency Service, HospitalFemaleFluid TherapyHumansLactic AcidMaleSepsisTreatment OutcomeAnti-Bacterial AgentsLactic Acidhospital mortalityquality improvementresuscitationsepsis

Identifiers

PMID26695114
PMCPMC4910898
OpenAlexW2214145300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.